Observation on the Therapeutic Efficacy of Modified Shoutai Pills in the Treatment of Polycystic Ovary Syndrome Complicated with Recurrent Spontaneous Abortion
10.13359/j.cnki.gzxbtcm.2025.03.013
- VernacularTitle:寿胎丸加味方治疗多囊卵巢综合征合并复发性流产的疗效观察
- Author:
Yan LUO
1
;
Yongju YE
;
Xianghui ZHOU
;
Yuan FANG
Author Information
1. 浙江省丽水市中医院,浙江丽水 323000
- Keywords:
modified Shoutai Pills;
polycystic ovary syndrome;
recurrent spontaneous abortion;
kidney deficiency and blood stasis syndrome;
ovarian function;
pregnancy outcome
- From:
Journal of Guangzhou University of Traditional Chinese Medicine
2025;42(3):621-628
- CountryChina
- Language:Chinese
-
Abstract:
Objective To observe the clinical efficacy of modified Shoutai Pills in the treatment of polycystic ovary syndrome(PCOS)complicated with recurrent spontaneous abortion(RSA).Methods Ninety-six patients with PCOS complicated with RSA of kidney deficiency and blood stasis syndrome admitted to Lishui Hospital of Traditional Chinese Medicine from January 2021 to January 2022 were randomly divided into the observation group and the control group,with 48 cases in each group.The control group was treated with progesterone,aspirin and low molecular weight heparin,while the observation group was treated with modified Shoutai Pills on the basis of treatment for the control group.The course of treatment covered one month and then the follow-up lasted for one year.The changes of traditional Chinese medicine(TCM)syndrome scores,ovarian reserve function indicators of antral follicle count and mean ovarian volume,and coagulation and fibrinolysis indicators of fibrinogen(FIB),activated partial thromboplastin time(APTT),prothrombin time(PT),and D-dimer(D-D)level before and after the treatment in the two groups were observed.After treatment,the clinical efficacy,total incidence of adverse reactions and pregnancy outcome of the two groups of patients were compared.Results(1)After one month of treatment,the total effective rate of the observation group was 95.83%(46/48),and that of the control group was 72.92%(35/48);the comparison between the two groups showed that the overall efficacy(tested by Ridit test)and the total effective rate(tested by chi-square test)of the observation group were significantly superior to those of the control group(P<0.05).(2)After treatment,the scores of spontaneous abortion frequency and TCM symptoms such as pain in the lower abdomen,fatigue and weakness,and dizziness and tinnitus in the two groups were decreased compared with those before treatment(P<0.05),and the decrease of the scores in the observation group was significantly superior to that in the control group(P<0.05).(3)After treatment,ovarian reserve function indicators of antral follicle count and mean ovarian volume in the two groups were improved compared with those before treatment(P<0.05),and the improvement in the observation group was significantly superior to that in the control group(P<0.05).(4)After treatment,coagulation and fibrinolysis indicators such as FIB,APTT,PT,and D-D in the two groups were improved compared with those before treatment(P<0.05),and the improvement in the observation group was significantly superior to that in the control group(P<0.05).(5)The total incidence of adverse reactions in the observation group was 6.25%(3/48),while that in the control group was 10.42%(5/48),and the comparison between the two groups showed that the difference was not statistically significant(P>0.05).(6)The rate of full-term delivery in the observation group was 87.50%(42/48),higher than that in the control group[45.83%(22/48)];the preterm birth rate and abortion rate of the observation group were 8.33%(4/48)and 4.17%(2/48),respectively,lower than those of the control group[all being 27.08%(13/48)],with the differences being statistically significant(P<0.05 or P<0.01).Conclusion Modified Shoutai Pills can effectively improve the ovarian function of patients with PCOS complicated with RSA,correct the hypercoagulable state,relieve abdominal pain and other symptoms,reduce the rate of preterm birth and abortion,and no obvious adverse reactions occurred in the patients during treatment.
